Improvement of pulmonary sarcoidosis following sleeve gastrectomy

Abstract

Pulmonary sarcoidosis is unlikely to resolve if it persists for greater than five years. A growing body of literature supports the involvement of the microbiome in sarcoidosis and a role for sex hormones in pulmonary fibrosis. Additionally, obesity is a risk factor for the development of sarcoidosis. Bariatric surgery is an effective treatment for obesity and can lead to microbial and endocrine changes. Here, we report the clinical improvement of longstanding pulmonary sarcoidosis following sleeve gastrectomy.

Keywords

Sarcoidosis / Bariatric surgery / Obesity / Estrogen / Microbiome

References

[1] Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet. 2014; 383(9923): 1155-67. PMid:24090799. https://doi.org/10.1016/S0140-6736(13)60680-7

[2] Cozier YC, Coogan PF, Govender P, et al. Obesity and weight gain in relation to incidence of sarcoidosis in US black women: data from the Black Women’s Health Study. Chest. 2015; 147(4): 1086-93. PMid:25411869. https://doi.org/10.1378/chest.14-1099

[3] Dumas O, Boggs KM, Cozier YC, et al.Prospective study of body mass index and risk of sarcoidosis in US women. Eur Respir J. 2017; 50(4). PMid:29051275. https://doi.org/10.1183/13993003.01397-2017

[4] Ungprasert P, Crowson CS, Matteson EL. Smoking, obesity and risk of sarcoidosis: A population-based nested case-control study. Respir Med. 2016; 120: 87-90. PMid:27817820. https://doi.org/10.1016/j.rmed.2016.10.003

[5] Cozier YC, Govender P, Berman JS. Obesity and sarcoidosis: consequence or contributor? Curr Opin Pulm Med. 2018; 24(5): 487-94. PMid:29979212. https://doi.org/10.1097/MCP.0000000000000503

[6] Mehrad M, Trejo BH, Yousem SA. Sex steroid receptor expression in idiopathic pulmonary fibrosis. Hum Pathol. 2017; 66: 200-5. PMid:28300574. https://doi.org/10.1016/j.humpath.2017.02.012

[7] Smith LC, Moreno S, Robertson L, et al. Transforming growth factor beta 1 targets estrogen receptor signaling in bronchial epithelial cells. Respir Res. 2018; 19(1): 160. PMid:30165855. https://doi.org/10.1186/s12931-018-0861-5

[8] Cozier YC, Berman JS, Palmer JR, et al.Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women’s Health Study. Am J Epidemiol. 2012; 176(7): 635-41. PMid:22967742. https://doi.org/10.1093/aje/kws145

[9] Shirai M, Sato A, Chida K. The influence of ovarian hormones on the granulomatous inflammatory process in the rat lung. Eur Respir J. 1995; 8(2): 272-7. PMid:7758563. https://doi.org/10.1183/09031936.95.08020272

[10] Geamanu A, Gupta SV, Bauerfeld C, et al. Metabolomics connects aberrant bioenergetic, transmethylation, and gut microbiota in sarcoidosis. Metabolomics. 2016; 12. PMid:27489531. https://doi.org/10.1007/s11306-015-0932-2

[11] Inaoka PT, Shono M, Kamada M, et al. Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis. J Biomed Sci. 2019; 26(1): 45. PMid:31182092. https://doi.org/10.1186/s12929-019-0537-6

[12] O’Dwyer DN, Ashley SL, Gurczynski SJ, et al. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019; 199(9): 1127-38. PMid:30789747. https://doi.org/10.1164/rccm.201809-1650OC

[13] Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999; 16(2): 149-73. PMid: 10560120.

[14] Baughman RP, Nagai S, Balter M, et al. Defining the clinical outcome status (COS) in sarcoidosis: results ofWASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis. 2011; 28(1): 56-64. PMid:21796892.

[15] Forno E, Han YY, Mullen J, et al. Overweight, Obesity, and Lung Function in Children and Adults-A Meta-analysis. J Allergy Clin Immunol Pract. 2018; 6(2): 570-81 e10. PMid:28967546. https://doi.org/10.1016/j.jaip.2017.07.010

[16] Martin Holguera R, Turrion Nieves AI, Rodriguez Torres R, et al. The effects of truncal adiposity in forced spirometry: Sex differences. Respir Physiol Neurobiol. 2018; 247: 167-73. PMid:29111228. https://doi.org/10.1016/j.resp.2017.10.009

[17] Nelson LR, Bulun SE. Estrogen production and action. J Am Acad Dermatol. 2001; 45(3 Suppl): S116-24. PMid:11511861. https: //doi.org/10.1067/mjd.2001.117432

[18] Sarwer DB, Wadden TA, Spitzer JC, et al.4-Year Changes in Sex Hormones, Sexual Functioning, and Psychosocial Status in Women Who Underwent Bariatric Surgery. Obes Surg. 2018; 28(4): 892-9. PMid:29164510. https://doi.org/10.1007/s11695-017-3025-7

[19] Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: Physiological and clinical implications. Maturitas. 2017; 103: 45-53. PMid:28778332. https://doi.org/10.1016/j.maturitas.2017.06.025

[20] Federico A, Dallio M, Tolone S, et al. Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery. In Vivo. 2016; 30(3): 321-30. PMid:27107092.

[21] Jahansouz C, Staley C, Bernlohr DA, et al. Sleeve gastrectomy drives persistent shifts in the gut microbiome. Surg Obes Relat Dis. 2017; 13(6): 916-24. PMid:28279578. https://doi.org/10.1016/j.soard.2017.01.003

[22] Murphy R, Tsai P, Jullig M, et al. Differential Changes in Gut Microbiota After Gastric Bypass and Sleeve Gastrectomy Bariatric Surgery Vary According to Diabetes Remission. Obes Surg. 2017; 27(4): 917-25. PMid:27738970. https://doi.org/10.1007/s11695-016-2399-2

[23] Campisciano G, Cason C, Palmisano S, et al. Bariatric surgery drives major rearrangements of the intestinal microbiota including the biofilm composition. Front Biosci (Elite Ed). 2018; 10: 495-505. PMid:29772522. https://doi.org/10.2741/e836

[24] Campisciano G, Palmisano S, Cason C, et al. Gut microbiota characterisation in obese patients before and after bariatric surgery. Benef Microbes. 2018; 9(3): 367-73. PMid:29482339. https://doi.org/10.3920/BM2017.0152

[25] Davies NK, O’Sullivan JM, Plank LD, et al. Altered gut microbiome after bariatric surgery and its association with metabolic benefits: A systematic review. Surg Obes Relat Dis. 2019; 15(4): 656-65. PMid:30824335. https://doi.org/10.1016/j.soard.2019.01.033

[26] Kilby KA, Kilbourne CM, Judson MA, et al. Considerations regarding sarcoidosis in the bariatric surgical patient. Surg Obes Relat Dis. 2018; 14(2): 219-24. PMid:29150393. https://doi.org/10.1016/j.soard.2017.10.007